The Brynildsen research group uses both computational and experimental techniques in systems biology, synthetic biology, and metabolic engineering to understand and address threats to human health. They currently focus on the global public health crisis of antibiotic resistance, and are interested in the specific areas of antivirulence therapy and bacterial persistence.
To sign up for the mailing list, please send a blank message to frontiers-qbio-join@lists.stanford.edu.